Holen Sie sich die Stockscreener-App
3.08
3.59%
-0.12
Schlusskurs vom Vortag:
$3.20
Offen:
$3.13
24-Stunden-Volumen:
256.85K
Relative Volume:
0.27
Marktkapitalisierung:
$227.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.81M
KGV:
-1.6383
EPS:
-1.88
Netto-Cashflow:
$74.30M
1W Leistung:
+2.83%
1M Leistung:
-18.17%
6M Leistung:
-69.67%
1J Leistung:
-20.18%
1-Tages-Spanne:
$3.05
$3.17
1-Wochen-Bereich:
$2.95
$3.25
52-Wochen-Spanne:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Firmenname
Omeros Corporation
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Vergleichen Sie OMER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
3.08 | 227.34M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.23 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
535.66 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
544.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.54 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corporation Aktie (OMER) Neueste Nachrichten
Ratios Revealed: Decoding Omeros Corporation (OMER)’s Financial Health - DWinneX
Omeros Co. (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
What is HC Wainwright’s Forecast for Omeros FY2025 Earnings? - Defense World
HC Wainwright Predicts Omeros’ Q2 Earnings (NASDAQ:OMER) - Defense World
Omeros (NASDAQ:OMER) Now Covered by Analysts at HC Wainwright - Defense World
Cantor Fitzgerald Comments on Omeros FY2026 Earnings - Defense World
Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga
Trend Tracker for (OMER) - news.stocktradersdaily.com
Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OME - GuruFocus
Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OMER Stock News - GuruFocus
HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target - MarketScreener
Omeros (OMER) Set for Growth with Potential Narsoplimab Approval - GuruFocus
Omeros (OMER) Set for Growth with Potential Narsoplimab Approval | OMER Stock News - GuruFocus
Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program - mx.advfn.com
Omeros (NASDAQ:OMER) Stock Rating Lowered by Wall Street Zen - Defense World
Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026 - mx.advfn.com
OMEROmeros Corporation Reports First Quarter 2025 Financial Results - mx.advfn.com
Squarepoint Ops LLC Has $316,000 Stake in Omeros Co. (NASDAQ:OMER) - Defense World
Millennium Management LLC Buys 27,088 Shares of Omeros Co. (NASDAQ:OMER) - Defense World
Two Sigma Advisers LP Decreases Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Corporation to Host Earnings Call - ACCESS Newswire
Nuveen Asset Management LLC Reduces Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Co. (NASDAQ:OMER) Shares Bought by Two Sigma Investments LP - Defense World
Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER) - Yahoo Finance
BNP Paribas Financial Markets Has $74,000 Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World
ProShare Advisors LLC Has $183,000 Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Corporation to acquire $80.5 million of its convertible senior notes due 2026 - MSN
Deutsche Bank AG Has $396,000 Stock Holdings in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros' Note Swap Causes Share Price Tumble - Finimize
Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster (OMER) - Seeking Alpha
Equities Analysts Issue Forecasts for Omeros FY2025 Earnings - Defense World
Omeros Co. (NASDAQ:OMER) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Omeros (NASDAQ:OMER) Rating Increased to Hold at StockNews.com - Defense World
Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance - MSN
Omeros (NASDAQ:OMER) Earns Hold Rating from Needham & Company LLC - Defense World
Omeros Corporation (NASDAQ:OMER) Q1 2025 Earnings Call Transcript - Insider Monkey
Omeros Co. (NASDAQ:OMER) Shares Purchased by Comerica Bank - Defense World
Omeros Corp. Earnings Call: Cautious Optimism Amid Challenges - TipRanks
Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic D - GuruFocus
Needham Reiterates Hold Rating on Omeros (OMER) | OMER Stock New - GuruFocus
Earnings call transcript: Omeros Q1 2025 sees stock rise post-earnings By Investing.com - Investing.com Nigeria
Omeros: Q1 Earnings Snapshot - CT Insider
Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ... - Yahoo Finance
Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab Launch Plans - GuruFocus
Omeros (OMER) Achieves Milestone with FDA Acceptance of Narsopli - GuruFocus
Omeros Corporation Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Omeros Q1 2025 sees stock rise post-earnings - Investing.com
Omeros (OMER) Streamlines Debt, Preps for Narsoplimab Launch - GuruFocus
Transcript : Omeros Corporation, Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Omeros Corp Q1 2025 Earnings: EPS of -$0.58 Misses Estimates, Re - GuruFocus
Omeros reports Q1 EPS (58c), consensus (60c) - TipRanks
Finanzdaten der Omeros Corporation-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):